Web Results

www.healio.com/news/pulmonology/20191220/year-in-review-new-treatment-options-updates-in-ild-ipf

Dec 26, 2019 ... Among patients with IPF, the antifibrotic medications pirfenidone and nintedanib were associated with significantly reduced risks for all-cause ...

www.verywellhealth.com/research-advances-in-idiopathic-pulmonary-fibrosis-4147729

So early forms of treatment for IPF were aimed largely at preventing or slowing the inflammatory process. Such treatments have included steroids, methotrexate,  ...

www.atsjournals.org/doi/full/10.1164/ajrccm.161.2.ats3-00

IPF is now recognized as a distinct clinical disorder. Despite major accomplishments in our understanding of the pathogenesis of lung fibrosis (1), the diagnosis ...

www.formularywatch.com/view/top-non-pharmacological-treatments-ipf

Feb 10, 2015 ... Because there was no approved medication treatment for idiopathic pulmonary fibrosis (IPF) until mid-October, 2014, physicians primarily ...

www.upmc.com/services/pulmonology/conditions/ipf

Treatment options for idiopathic pulmonary fibrosis. At present, there are no approved drug therapies for IPF, but patients may benefit from: Pulmonary ...

rarediseases.org/rare-diseases/idiopathic-pulmonary-fibrosis

Although there is no cure for IPF, various different treatments are available to manage the disorder and several newer therapeutic options are being studied.

jtd.amegroups.com/article/view/28653/html

Comprehensive treatment plans for IPF should also address several non- pharmacological management options that may affect quality of life. Smoking cessation, ...

medicalxpress.com/news/2019-09-treatment-pulmonary-fibrosis.html

Sep 25, 2019 ... However, it is not clear what the cause of this condition is, and while there are two treatments that can help slow the rate at which IPF progresses, ...

www.fda.gov/media/91396/download

At the date of this meeting (September 26, 2014), there were no approved therapies specifically for the treatment of IPF and the slowing of disease progression.1.

www.ucsf.edu/news/2020/10/418766/inhalable-treatment-enhances-regeneration-lung-fibrosis-model

Oct 12, 2020 ... IPF is characterized by progressive scarring – with no identifiable cause – of the sensitive lung tissue responsible for exchanging blood CO2 for ...